BioSpace News Archive

The study of the 53 patients in the U.S., Europe and Canada who required respiratory support showed that about two-thirds benefited from the drug.

The U.S. Food and Drug Administration granted emergency use authorization to Rutgers’ RUCDR Infinite Biologics for its test that uses saliva.

Cytel Inc. has launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater collaboration between researchers, policymakers, clinicians, journalists, philanthropists, and other critical stakeholders who need to understand the complex dynamics of the global response to finding a solution to the COVID-19 outbreak.

Eli Lilly will begin exploring the use of its rheumatoid arthritis drug Olumiant as a treatment for hospitalized patients with COVID-19. A clinical trial will begin this month and results are expected within the next two months.

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 13, 2020.

Although the COVID-19 death toll has not yet reached the numbers of H3N2, it still continues to climb.

Bristol Myers Squibb is prepared for an additional windfall of cash after a judge boosted the damages the company is due from Gilead Sciences over a patent infringement regarding the technology related to a novel cancer therapy.

This article offers suggestions for how to be camera-ready for a virtual interview.

The Stanford serology test provides results in two to three days and Stanford Health Care can test 500 samples per day. Know what more it has to offer.

In its daily blog about the precautions the company is taking to ensure continued service to the world, Amazon said it will build its own testing facilities for employees.